clinical_trial

AAV-GBA1 Gene Therapy in Parkinson's (PR001)

created 4/30/2026, 2:41:24 PM

History Diff Edit
active phase_2 NCT04127578
Intervention
PR001 (AAV9-GBA1 intracisternal)
Sponsor
Prevail Therapeutics / Lilly
Registered
Apr 30, 2026

Voting as anonymous. Sign in to attribute your signals.

tokens

Replication

No replications yet

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.